FibroBiologics FBLG
NASDAQ FBLG
$1.02 +0.02 (+2.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

FibroBiologics (FBLG) Debt Ratio (2022 - 2026)

Updated

FibroBiologics' Debt Ratio was 0.02 in Q2 2026, down 97.3% from 0.58 a year earlier and down 62.3% from the prior quarter.

Analysis

FibroBiologics (FBLG) Debt Ratio (2022 - 2026) Analysis & Trends

For FY2025, Debt Ratio at FibroBiologics came in at 1.21, up 98.3% from FY2024.

  • In earlier years, Debt Ratio was 0.61 in FY2024 and 1.13 in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Debt Ratio since Q3 2024.
  • Per Business Quant data, FBLG's Debt Ratio in the three quarters before Q2 2026 was 0.04 (Q1 2026), 1.21 (Q4 2025) and 1.11 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 FibroBiologics 6.40 Mn -8.42 Mn - 0.02
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.02
Mar 31, 2026 0.04
Dec 31, 2025 1.21
Sep 30, 2025 1.11
Jun 30, 2025 0.58
Mar 31, 2025 0.51
Dec 31, 2024 0.61
Sep 30, 2024 0.01
Jun 30, 2024 0.03
Mar 31, 2024 0.04
Dec 31, 2022 1.13
API Access

FibroBiologics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=FBLG&period=max&api_key=YOUR_API_KEY